Chimeric foot-and-mouth disease virus serotype O displaying a serotype Asia1 antigenic epitope at the surface

[1]  B. Pattnaik,et al.  Engineering foot-and-mouth disease virus serotype O IND R2/1975 for one-step purification by immobilized metal affinity chromatography. , 2015, Biologicals : journal of the International Association of Biological Standardization.

[2]  R. Kormelink,et al.  Feasibility of Cowpea chlorotic mottle virus-like particles as scaffold for epitope presentations , 2015, BMC Biotechnology.

[3]  M. Rahman,et al.  Antigenic heterogeneity of capsid protein VP1 in foot-and-mouth disease virus (FMDV) serotype Asia 1 , 2013, Advances and applications in bioinformatics and chemistry : AABC.

[4]  Decheng Yang,et al.  Insertion of type O-conserved neutralizing epitope into the foot-and-mouth disease virus type Asia1 VP1 G-H loop: effect on viral replication and neutralization phenotype. , 2012, The Journal of general virology.

[5]  Li Yu,et al.  Identification of a conformational epitope on the VP1 G-H Loop of type Asia1 foot-and-mouth disease virus defined by a protective monoclonal antibody. , 2011, Veterinary microbiology.

[6]  B. Charleston,et al.  Options for control of foot-and-mouth disease: knowledge, capability and policy , 2009, Philosophical Transactions of the Royal Society B: Biological Sciences.

[7]  H. Thulke,et al.  High potency vaccines induce protection against heterologous challenge with foot-and-mouth disease virus. , 2008, Vaccine.

[8]  B. Baxt,et al.  Foot-and-Mouth Disease , 2004, Clinical Microbiology Reviews.

[9]  A. Sanyal,et al.  Antigenic characterization of foot-and-mouth disease virus serotype Asia1 field isolates using polyclonal and monoclonal antibodies. , 2003, Veterinary microbiology.

[10]  D. Mackay,et al.  A solid-phase competition ELISA for measuring antibody to foot-and-mouth disease virus. , 2001, Journal of virological methods.

[11]  T. Macnaughton,et al.  Antigenicity and Immunogenicity of Novel Chimeric Hepatitis B Surface Antigen Particles with Exposed Hepatitis C Virus Epitopes , 2001, Journal of Virology.

[12]  J. Casal,et al.  Parvovirus-like particles as vaccine vectors. , 1999, Methods.

[13]  C. Leclerc,et al.  Engineering parvovirus-like particles for the induction of B-cell, CD4(+) and CTL responses. , 1999, Vaccine.

[14]  M. Fernández-Fernández,et al.  Development of an antigen presentation system based on plum pox potyvirus , 1998, FEBS letters.

[15]  E. Domingo,et al.  A Similar Pattern of Interaction for Different Antibodies with a Major Antigenic Site of Foot-and-Mouth Disease Virus: Implications for Intratypic Antigenic Variation , 1998, Journal of Virology.

[16]  D. Stuart,et al.  Arginine-glycine-aspartic acid-specific binding by foot-and-mouth disease viruses to the purified integrin alpha(v)beta3 in vitro , 1997, Journal of virology.

[17]  H. Katinger,et al.  Immunogenic presentation of a conserved gp41 epitope of human immunodeficiency virus type 1 on recombinant surface antigen of hepatitis B virus. , 1996, The Journal of general virology.

[18]  E. Domingo,et al.  Direct evaluation of the immunodominance of a major antigenic site of foot-and-mouth disease virus in a natural host. , 1995, Virology.

[19]  P. Mason,et al.  Vaccines prepared from chimeras of foot-and-mouth disease virus (FMDV) induce neutralizing antibodies and protective immunity to multiple serotypes of FMDV , 1994, Journal of virology.

[20]  D. Stuart,et al.  Structure of a major immunogenic site on foot-and-mouth disease virus , 1993, Nature.

[21]  David Rowlands,et al.  The three-dimensional structure of foot-and-mouth disease virus at 2.9 Å resolution , 1989, Nature.

[22]  H. L. Bachrach,et al.  A plaque assay for foot-and-mouth disease virus and kinetics of virus reproduction. , 1957, Virology.

[23]  Md. Rejwanul Hossain,et al.  Advances and Applications in Bioinformatics and Chemistry Dovepress Antigenic Heterogeneity of Capsid Protein Vp1 in Foot-and-mouth Disease Virus (fmdv) Serotype Asia1 , 2022 .

[24]  B. Delmas,et al.  Infectious bursal disease subviral particles displaying the foot-and-mouth disease virus major antigenic site. , 2009, Vaccine.